Bio Tie Therapies entered into licensing agreement
Biotie Therapies entered into a licensing agreement on its VAP-1 antibody program with the Japanese company Seikagaku Corporation. The agreement is valued at USD 16.7 million, including a signing fee and milestone payments.
| |
LAB International Licenses Fentanyl Taifun® for Japan
LAB International Inc. (“LAB”) drug development subsidiary, LAB Pharma Ltd., and Teikoku Seiyaku Co. Ltd. have entered into a licensing and development agreement for Fentanyl TAIFUN®, LAB’s fast-acting Fentanyl formulation, for the Japanese market. | |
Biothera
Biothera’s Pharmaceutical Group is developing immunomodulatory compounds that work synergistically with monoclonal antibodies to engage and direct the killing power of neutrophils against cancer. The lead compound, Imprime PGG®, is currently in multiple Phase II clinical trials and a Phase III trial for colorectal cancer. | |
Human GmbH
Since 1972 Human GmbH has manufactured and supplied a comprehensive range of reliable, quality diagnostic tests and laboratory equipment. Nowadays the products are available in over 160 countries by branch offices and qualified distributors. HUMAN's vision is to become a synonym for Diagnostics Worldwide. | |
Other
Licensing operation in Japan for a spin-off from a big pharmaceutical company.
Global Japanese medical equipment company for business development in Europe and USA.
Clinical development coordination in Europe for a Japanese pharmaceutical company. | |
Supporting Japanese biopharma company to collect funding.
European biotech company for in-licensing operation in Japan.
A leading Scandinavian diagnostic company for distribution arrangements in Japan.
Market intelligence services for a global life-science company. | |
A global industrial equipment company with healthcare unit for business development and licensing in Japan.
Japanese biotech venture company for out-licensing in Europe and USA.
Business plan development and strategic advice for a leading CNS biotech.
A European Academic technology transfer office for licensing operations in Japan.
Relation management services with European opinion leaders for a Japanese pharmaceutical company. | |
 |  
  |
  |  |
 |  
  |
